The distinctive nature of HER2-positive gastric cancers

被引:13
|
作者
Marano, L. [1 ]
Roviello, F. [1 ]
机构
[1] Univ Siena, Dept Med Surg & Neurosci, Unit Gen & Minimally Invas Surg, I-53100 Siena, Italy
来源
EJSO | 2015年 / 41卷 / 03期
关键词
HER2; EXPRESSION; RECEPTOR; PROTEIN;
D O I
10.1016/j.ejso.2014.12.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:271 / 273
页数:3
相关论文
共 50 条
  • [31] Treatment strategies for patients with HER2-positive gastric cancer
    Wang, Feixue
    Ba, Yi
    CANCER BIOLOGY & MEDICINE, 2023, 20 (12) : 934 - 941
  • [32] MicroRNA Signature for HER2-positive Breast and Gastric Cancer
    Kim, Joseph
    Jang, Sang-Geun
    Kwon, Sun Young
    Park, Young Soo
    Kang, Han Sung
    Green, Jeffrey E.
    Kim, Hark Kyun
    Ro, Jungsil
    ANTICANCER RESEARCH, 2014, 34 (07) : 3807 - 3810
  • [33] Current Targeted Therapies in HER2-Positive Gastric Adenocarcinoma
    Curea, Fabiana G.
    Hebbar, Mohamed
    Ilie, Silvia M.
    Bacinschi, Xenia E.
    Trifanescu, Oana G.
    Botnariuc, Inga
    Anghel, Rodica M.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2017, 32 (10) : 351 - 363
  • [34] A phenotypic and mechanistic perspective on heterogeneity of HER2-positive breast cancers
    Ferrari, Anthony
    Sertier, Anne-Sophie
    Vincent-Salomon, Anne
    Pivot, Xavier
    Pauporte, Iris
    Saintigny, Pierre
    Birnbaum, Daniel
    Viari, Alain
    MOLECULAR & CELLULAR ONCOLOGY, 2016, 3 (06)
  • [35] Updates in HER2-Positive and Triple-Negative Breast Cancers
    Telli, Melinda L.
    Gradishar, William J.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 605 - 609
  • [36] Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers
    Chuang, Jeremy
    Klempner, Samuel
    Waters, Kevin
    Atkins, Katelyn
    Chao, Joseph
    Cho, May
    Hendifar, Andrew
    Gangi, Alexandra
    Burch, Miguel
    Mehta, Pareen
    Gong, Jun
    DISEASES, 2022, 10 (02)
  • [37] Emerging insights into mechanisms of trastuzumab resistance in HER2-positive cancers
    Wu, Xiaoxue
    Huang, Shuting
    He, Weiling
    Song, Mei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122
  • [38] The influence of ER on small HER2-positive invasive breast cancers
    Caggiano, V.
    Parise, C.
    Bauer, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] Biologicals to direct nanotherapeutics towards HER2-positive breast cancers
    Kumar, Gautam
    Nandakumar, Krishnadas
    Mutalik, Srinivas
    Rao, Chamallamudi Mallikarjuna
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2020, 27 (27)
  • [40] Improving Therapy for HER2-Positive Cancers Through Neoadjuvant Studies
    Krop, Ian
    ONCOLOGY-NEW YORK, 2012, 26 (01): : 34 - +